fashion -WSS

fashion

author：leisure time 2025-08-23 08:52:56 - browse：11979

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： ADA: All diabetes patients should be screened for liver condition

WSS

Supreme Court strikes down Biden student loan forgiveness program

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Vermont grapples with historic flooding as more rainstorms head for Northeast

Illumina to lay off 10% of research and development team

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Eating disorder hotline's move to chatbot carried cost for volunteers

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

In Memoriam: Notable people who died in 2023

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Psychedelics group wrestles with new pharma identity

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Peter Hotez and the public health issue of online harassment

Supreme Court rules employers must be more accommodating of religious observance

What does generative AI mean for health care? We asked experts

EU fines Illumina $475 million over Grail acquisition

knowledge

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Britney Spears to release memoir, 'The Woman In Me,' later this year

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Wikipedia

hotspot

focus

explore